Search

everythinglearnresearchcommunity

for

Search:↓

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Genes and hormones cause hair loss, with four genes contributing equally.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Goat reproductive activity and coat growth are affected by light and temperature, with temperature altering prolactin levels and hair growth, but not melatonin or estrus onset.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Iron deficiency may contribute to hair loss.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

There is no significant link between male pattern baldness and insulin resistance.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Mutations in certain receptors can cause diseases and offer new treatment options.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.